Depression is a common comorbidity in people living with HIV, with lifetime prevalence estimates ranging from 22% to 61%.
As part of the World Health Organization’s goal to eliminate viral hepatitis as a global health threat by 2030, the incidence of chronic new infections must decrease by 90%.
For patients with serious infectious diseases, the first 48 hours represent a critical window for antibiotic administration.
There is a lack of consensus among experts and professional organizations whether HCV screening in pregnant women should be risk based or universal.
Adolescents infected with HIV have a greater risk for psychiatric hospitalizations compared with those not infected with HIV.
Children infected with hepatitis C face environmental, provider, and system-based challenges, such as underreporting.
There is an opportunity to improve HCV treatment rates for people who inject drugs by integrating DAA therapy into current models of community-based addiction.